Prosecution Insights
Last updated: July 17, 2026
Application No. 18/539,559

OIL-RESISTANT AGENT

Final Rejection §103
Filed
Dec 14, 2023
Priority
Jun 22, 2021 — JP 2021-103440 +2 more
Examiner
GALSTER, SAMUEL LEONARD
Art Unit
1693
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Daikin Industries Ltd.
OA Round
2 (Final)
53%
Grant Probability
Moderate
3-4
OA Rounds
7m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allowance Rate
58 granted / 109 resolved
-6.8% vs TC avg
Strong +41% interview lift
Without
With
+40.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
51 currently pending
Career history
161
Total Applications
across all art units

Statute-Specific Performance

§103
53.2%
+13.2% vs TC avg
§102
4.3%
-35.7% vs TC avg
§112
2.8%
-37.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 109 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The amendment to the claims and specification filed April 6, 2026 have been entered. Claims 1, 3-4, 6, 13-14, have been amended, claim 15 has been cancelled. Applicant’s amendments to the claims have overcome the objections to the claims and specification, the 112b, 112d rejections previously set forth in the Non-Final Office Action mailed December 5, 2025. Applicants cancellation of claim 15 have rendered the corresponding rejections/objections moot. As such, these rejections and objections are hereby withdrawn. Applicant’s arguments filed April 6, 2026 were fully considered but they were not persuasive. Maintained/modified rejections necessitated by Applicant’s amendment are addressed below. Claims 1-14 and 16-19 are pending in this application. Election/Restrictions Applicant’s election without traverse of Group I claims 1-15 (drawn to an oil resistant agent and products) in the reply filed on October 10, 2025 is acknowledged. Thus, claims 16-19 are withdrawn due to being directed to a non-elected invention and claim 15 has been cancelled. Thus claims 1-14 are examined herein. Priority This application is a CON of PCT/JP2022/024780 filed June 21, 2022 and claims foreign priority to JP 2022-019806 filed February 10, 2022 and JP 2021-103440 filed June 22, 2021. Acknowledgment is made of applicant’s claim for foreign priority under 35 U.S.C. 119 (a)-(d). The certified copy has been received. The Examiner notes that no English translation was provided. Claim Interpretation Claim 1 recites an oil-resistant agent, comprising a modified natural product. The broadest reasonable interpretation of the oil-resistant agent, is the modified natural product itself. According the instant specification the oil-resistant agent exhibits oil resistance and imparts the oil resistance to a treatment target by treating the treatment target with the oil-resistant agent (pg. 4, para. 0010) That is, the phrase “oil-resistant” is merely a description of a property of the agent or a property that occurs following application. Additionally the property of a given agent cannot be separated from the product given an identical product is taught in the prior art. Modified Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 1-3, and 5-14 are rejected under 35 U.S.C. 103 as being unpatentable over Nakagawa (CN 112779772, cited in previous action). Regarding claims 1-3 and 5-14: Nakagawa teaches a water repellent composition comprising a dehydration condensate of a 2-to-4 membered polycarboxylic acid and a hydrocarbon alcohol or amine wherein the alkyl group has 6 to 22 carbon atoms (English translation, abstract). According to the instant specification, the instant oil-resistant agent can be used as a water repellant (pg. 62, lines 1-4). Nakagawa teaches the specific preparation: citric acid monohydrate reacted with dihydrotallow amine (trade name “Armeen 2HT”) in a condensation reaction forming a diamide compound as the main component (English translation, pg. 13, second to last para., production example 1). According to Nouryon, Armeen 2HT is a dialkyl amine of formula R-NH-R wherein R is an alkyl chain mainly C16-C18 (pg. 1, para. 1). Nakagawa teaches the resulting condensate (a1) has a melting point of 52-56 °C (English translation, pg. 13, second to last para., production example 1, i.e. higher than 25 °C). The condensate (a1) is then combined with an anionic surfactant and emulsified to prepare an aqueous dispersion (English translation, pg. 13, second to last para., production example 1). Nakagawa teaches in view of emulsifiability of the product, the components are adjusted so that least 1 carboxyl group form an ester/amide, and at least 0 to 1 carboxyl group remains unreacted (English translation, pg. 5, middle of page, para. 9). Unreacted carboxyl groups can be in the form of a carboxyl group, or exist as a salt of the carboxyl group (English translation, pg. 5, para. 13). Although Nakagawa does not determine the bio-based percentage of the product, considering a majority of the carbons are from bio-based ingredients (i.e. tallow), and not petroleum sources (instant specification, pg. 5, para. 0011) it is presumed to be higher than 30% as instantly claimed, absent evidence to the contrary. Although, Nakagawa is directed towards the application of the repellent towards fibers, as discussed above in the claim interpretation, the “intended use” of a composition or product, e.g., “for paper”, will not further limit claims drawn to a composition, so long as the prior art discloses the same composition comprising the same ingredients in an effective amount, as the instantly claimed. Thus, claim 15 is also anticipated. Nakagawa teaches the composition can further include pH adjusters, including citric acid (English translation, pg. 9, second to last para., pg. 10, para. 2), thereby anticipating claim 12. However, Nagakawa teaches stearyl amine can be used as an alternative to dihydrotallow amine (English translation, pg. 5, para. 4). Given that they are possible alternatives encompassed by the formula of Nagakawa, it is prima facie obvious to substitute equivalents known for the same purpose (See MPEP 2144.06 (II)). Taken together it would have been prima facie obvious to arrive at a citric acid modified with stearyl amine as taught by Nagakawa. A person of ordinary skill in the art would have had the motivation to do so with a reasonable expectation of success as Nagakawa teaches stearyl amine as a suitable alternative and it is prima facie obvious to substitute equivalents known for the same purpose. According to the instant specification, Example 1 is prepared from the reaction between citric acid and octadecyl amine (i.e. stearylamine, pgs. 49-50, para. 0125). This example results in the formation of citric acid in which carboxylic acid groups have been replaced with octadecyl amides (i.e. stearyl amine connected to a carboxyl group). The instant specification demonstrates that the contact angle of this compound is 46.5 and has a melting point of 100 °C (pg. 51, para. 0128, table 1). The instant specification states the biobased content is 100 % (pgs. 49-50, para. 1, example 1). Thus, wherein it would have been obvious to substitute dihydrotallow amine with stearyl amine, a person of ordinary skill in the art would be motivated to arrive at Example 1 as described in the instant specification, which necessarily has a contact angle, melting point, and biobased content within the claimed range, absent evidence to the contrary. Claims 1, 3-8 and 13-14 are rejected under 35 U.S.C. 103 as being unpatentable over Rodriguez Gonzales (WO 2010/101477, cited in previous action), hereinafter referred to as Rodriguez. Regarding claims 1, 3-8 and 13-14: Rodriguez teaches compounds and compositions of citric acid trialkylamides (citramides) for controlling gas hydrate formation (abstract, pg. 1, lines. 1-4). Rodriguez teaches the citric acid derivatives have the following formula: PNG media_image1.png 183 101 media_image1.png Greyscale PNG media_image2.png 156 504 media_image2.png Greyscale (pg. 6, lines 1-8). Rodriguez teaches tributyl citrate and acetyl tributyl citrate as possible compounds (pg. 10, lines 15-21, table 1). These compounds meet the structural limitations as recited by instant claims 1 and 3-8. Rodriguez teaches the compounds are to be dissolved in water at 1-2 wt% (pg. 18, bottom of page). Although, Rodriguez is directed towards the application of the agent for controlling gas hydrate formation as discussed above in the claim interpretation, the “intended use” of a composition or product, e.g., “for paper”, will not further limit claims drawn to a composition, so long as the prior art discloses the same composition comprising the same ingredients in an effective amount, as the instantly claimed. According to the instant specification, Example 1 is prepared from the reaction between citric acid and octadecyl amine (i.e. stearylamine, pgs. 49-50, para. 0125). This example results in the formation of citric acid in which carboxylic acid groups have been replaced with octadecyl amides (i.e. stearyl amine connected to a carboxyl group). The instant specification demonstrates that the contact angle of this compound is 46.5 and has a melting point of 100 °C (pg. 51, para. 0128, table 1). Given that the trialkyl citramides encompassed by Rodriguez are similar in structure to those in the instant specification, the compounds encompassed by Rodriguez meet the structural limitations of the instant claims and thus necessarily have a melting point >60 °C and HD contact angle of 10 degree or larger absent evidence to the contrary. Response to Arguments Applicant’s arguments filed April 6, 2026 with respect to the claims have been fully considered but they are not persuasive. On pages 11 (last para.) and 12 (para. 1) of Applicant’s response, Applicant argues the compound of Nakagawa is a long-chain dialkyl amine, wherein the examples of the present application use a monoalkyl amine rather than a dialkylamine, and amended claim 1 limits some of R11 and R12 in the linker moiety to those having 4 or fewer carbon atoms. On page 12 of Applicant’s response, Applicant argues the amended claim recites that the oil resistant agent has a melting point of 60 C or higher, distinguishing from Nakagawa (para. 3). However, see modified 103 rejections above, wherein the prior art renders obvious a composition comprising the claimed compound which has the claimed properties. On page 12 of Applicants Response, Applicant argues that the present specification demonstrates excellent oil resistance, especially high temperature oil resistance (para. 5). Applicant argues the melting point of the oil-resistant agent in the above range improves resistance to temperature (para. 5). In short applicant argues that the high melting point accounts for its improved temperature resistance Applicant argues that the documents do not mention oil resistance, only referring to water repellency which are based on different mechanism and could not have been predicted (last para.). However, these features are innate features to the compound. Additionally, the instant specification demonstrates static contact angle and melting point for two specific compounds, so even if the argument were found to be persuasive, the argued unexpected results are not commensurate with the scope of the claims (See MPEP 716.02(d). Applicant’s reply is considered to be a bona fide attempt at a response and is being accepted as a complete response. The 35 USC § 103 rejections are maintained for reason of record and foregoing discussion. Conclusion No claims are allowed in this action. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SAMUEL L GALSTER whose telephone number is (571)270-0933. The examiner can normally be reached Monday - Friday 8:00 AM - 5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Y Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /S.L.G./Examiner, Art Unit 1693 /ANDREA OLSON/Primary Examiner, Art Unit 1693
Read full office action

Prosecution Timeline

Dec 14, 2023
Application Filed
Dec 05, 2025
Non-Final Rejection mailed — §103
Apr 06, 2026
Response Filed
May 15, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12648956
Pentagalloyl Glucose Derived from Schinus Plants and Methods of Use
3y 9m to grant Granted Jun 09, 2026
Patent 12637488
METHOD FOR THE SYNTHESIS OF IRIDIUM ORGANOMETALLIC MATERIAL
5y 8m to grant Granted May 26, 2026
Patent 12600743
METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND
3y 11m to grant Granted Apr 14, 2026
Patent 12599611
METHODS AND COMPOSITIONS FOR TREATING SEIZURE DISORDERS IN PEDIATRIC PATIENTS
3y 10m to grant Granted Apr 14, 2026
Patent 12583880
SEPARATION OF OLIGOSACCHARIDES
4y 9m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
53%
Grant Probability
94%
With Interview (+40.6%)
3y 2m (~7m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 109 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month